XOMA Royalty (XOMAP) Officer Acquires 3,033 PSUs on 09/19/2025
Maricel P. Montano, Chief Legal Officer and Director of XOMA Royalty Corp (XOMA), reported insider transactions dated 09/19/2025.
Rhea-AI Filing Summary
Maricel P. Montano, Chief Legal Officer and Director of XOMA Royalty Corp (XOMA), reported insider transactions dated 09/19/2025. The filing shows acquisition of 3,033 Performance Stock Units (PSUs) and 3,033 shares of Common Stock recorded as acquired with $0 price, with PSUs vesting upon the company's common stock reaching a specified price per share. After the reported transactions the filing lists 12,134 shares of common stock and 11,316 derivative units beneficially owned following the transactions. The PSUs have a stated date exercisable of 05/18/2026 per the filing. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Montano on 09/23/2025.
Positive
- Reported acquisition of 3,033 Performance Stock Units (PSUs), showing the reporting person received performance-based equity
- PSUs vest upon achieving a specified price per share, aligning compensation with share-price performance
- Form 4 discloses post-transaction beneficial ownership totals (12,134 common shares; 11,316 derivative units), providing transparency
Negative
- None.
Insights
TL;DR: Insider reported acquisition of performance-based equity that vests on a stock-price condition, modest in absolute size.
The Form 4 documents a non-cash award structure: 3,033 Performance Stock Units and 3,033 common shares are recorded as acquired on 09/19/2025 at a reported price of $0, consistent with compensation or performance-based awards rather than open-market purchases. The PSUs convert to one share each upon achieving a specified stock-price threshold and are listed exercisable beginning 05/18/2026. Reported beneficial ownership totals (12,134 common stock; 11,316 derivative units) reflect Ms. Montano's current holdings after these transactions. This disclosure is standard for executive compensation and aligns the reporting person’s incentives with future stock performance.
TL;DR: Director/officer received performance units tied to share price, a common governance mechanism to align executive incentives.
The filing shows a performance-based equity grant structure where vesting is contingent on a share-price metric. The documentation on this Form 4 is limited to the transaction details and the basic vesting trigger; it does not provide the specific price target or full award agreement terms. The report was executed by an attorney-in-fact, as indicated by the signature block dated 09/23/2025. From a governance perspective, such awards are typical but material assessment would require the underlying award terms and potential dilution impact, which are not included in this Form 4.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Stock Units | 3,033 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,033 | $0.00 | $0.00 |
Footnotes (1)
- F1. Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock (the "Common Stock"). The PSUs vest upon the Common Stock achieving a specified price per share.
FAQ
What did Maricel P. Montano acquire on 09/19/2025 for XOMA (XOMAP)?
What is the exercisable date for the PSUs reported by Maricel Montano?
What triggers vesting of the Performance Stock Units in this filing?
Who signed the Form 4 for Maricel Montano and when?
AI-generated analysis. How Rhea-AI works. Not financial advice.